SIM
AST

Spark Investment Management’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Spark Investment Management’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-68,600
Closed -$269K – 934
2015
Q4 		$269K Buy
+68,600
New +$316K 0.03% 506

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Spark Investment Management's AST Position: Q1 2016 in Review

Spark Investment Management sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2016, closing a stake of 68,600 shares — an estimated $269K sold.

Spark Investment Management first reported a position in AST in Q4 2015 and held it in 1 quarter. The position peaked at $269K in Q4 2015. 55 funds tracked by Wall St. Rank hold AST as of Q1 2016.

  • Spark Investment Management reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2016 after selling out during the quarter.
  • Spark Investment Management sold 68,600 Asterias Biotherapeutics Inc. Series A shares in Q1 2016, an estimated $269K.
  • Spark Investment Management first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2015 and held it in 1 quarter.
  • Spark Investment Management's Asterias Biotherapeutics Inc. Series A position peaked at $269K in Q4 2015.
  • 55 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2016.

Based on Spark Investment Management's 13F filing for Q1 2016, filed 12 May 2016.